- Home
- PBPB vs BNTC Comparison
PBPB vs BNTC Comparison
Compare PBPB & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBPB
- BNTC
- Stock Information
- Founded
- PBPB 1977
- BNTC 1995
- Country
- PBPB United States
- BNTC United States
- Employees
- PBPB N/A
- BNTC N/A
- Industry
- PBPB Restaurants
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- PBPB Consumer Discretionary
- BNTC Health Care
- Exchange
- PBPB Nasdaq
- BNTC Nasdaq
- Market Cap
- PBPB 278.1M
- BNTC 339.8M
- IPO Year
- PBPB 2013
- BNTC N/A
- Fundamental
- Price
- PBPB $9.48
- BNTC $14.67
- Analyst Decision
- PBPB Strong Buy
- BNTC Strong Buy
- Analyst Count
- PBPB 3
- BNTC 7
- Target Price
- PBPB $15.33
- BNTC $24.43
- AVG Volume (30 Days)
- PBPB 356.9K
- BNTC 51.9K
- Earning Date
- PBPB 03-06-2025
- BNTC 05-12-2025
- Dividend Yield
- PBPB N/A
- BNTC N/A
- EPS Growth
- PBPB 670.59
- BNTC N/A
- EPS
- PBPB 1.31
- BNTC N/A
- Revenue
- PBPB $462,598,000.00
- BNTC N/A
- Revenue This Year
- PBPB $5.67
- BNTC N/A
- Revenue Next Year
- PBPB $3.78
- BNTC N/A
- P/E Ratio
- PBPB $7.22
- BNTC N/A
- Revenue Growth
- PBPB N/A
- BNTC N/A
- 52 Week Low
- PBPB $6.28
- BNTC $4.75
- 52 Week High
- PBPB $13.48
- BNTC $16.90
- Technical
- Relative Strength Index (RSI)
- PBPB 39.73
- BNTC 57.19
- Support Level
- PBPB $8.89
- BNTC $14.90
- Resistance Level
- PBPB $9.64
- BNTC $16.90
- Average True Range (ATR)
- PBPB 0.49
- BNTC 1.17
- MACD
- PBPB -0.03
- BNTC 0.05
- Stochastic Oscillator
- PBPB 24.13
- BNTC 57.12
About PBPB Potbelly Corporation
Potbelly Corp owns and franchises hundreds of limited-service restaurants specializing in sandwiches and salads, shakes. The menu includes toasty sandwiches, signature salads, soups, chili, sides, desserts, and, in breakfast locations it serves breakfast sandwiches and steel-cut oatmeal. majority of its locations are company-owned and located in the United States, with Illinois and Texas housing far more locations than any other state. The company has franchise partners in a number of countries. Excluding the United States, its franchises are in the Middle East.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.